Amgen (AMGN) Accumulated Depreciation & Amortization (2009 - 2025)
Amgen's quarterly Accumulated Depreciation & Amortization came in at $5.2 billion in Q4 2025, down 7.6% year-on-year from $5.6 billion in Q4 2024, and down 7.6% quarter-over-quarter from $5.6 billion in Q4 2024.
Amgen has reported Accumulated Depreciation & Amortization for 17 years, with the latest figure at $5.2 billion in Q4 2025.
- For the quarter ending Q4 2025, Accumulated Depreciation & Amortization fell 7.6% year-over-year to $5.2 billion; the trailing twelve-month figure through Dec 2025 stood at $5.2 billion (down 7.6% YoY), and the FY2025 full-year result was $5.2 billion, down 7.6% from the prior year.
- Accumulated Depreciation & Amortization for Q4 2025 stood at $5.2 billion, down from $5.6 billion in the prior quarter.
- The five-year high for Accumulated Depreciation & Amortization was $5.6 billion in Q4 2024, with the low at $3.4 billion in Q4 2021.
- Average Accumulated Depreciation & Amortization over 5 years is $4.3 billion, with a median of $4.1 billion recorded in 2023.
- Year-over-year, Accumulated Depreciation & Amortization soared 37.36% in 2024 and dropped 7.6% in 2025.
- Tracing AMGN's Accumulated Depreciation & Amortization over 5 years: stood at $3.4 billion in 2021, then climbed by 0.56% to $3.4 billion in 2022, then grew by 19.14% to $4.1 billion in 2023, then surged by 37.36% to $5.6 billion in 2024, then dropped by 7.6% to $5.2 billion in 2025.
- The last three Accumulated Depreciation & Amortization figures came in at $5.2 billion (Q4 2025), $5.6 billion (Q4 2024), and $4.1 billion (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 5.17 Bn |
| Dec 31, 2025 | 5.17 Bn |
| Dec 31, 2024 | 5.59 Bn |
| Dec 31, 2024 | 5.59 Bn |
| Dec 31, 2023 | 4.07 Bn |
| Dec 31, 2023 | 4.07 Bn |
| Dec 31, 2022 | 3.42 Bn |
| Dec 31, 2022 | 3.42 Bn |
| Dec 31, 2021 | 3.40 Bn |
| Dec 31, 2021 | 3.40 Bn |
| Dec 31, 2020 | 3.60 Bn |
| Dec 31, 2020 | 3.60 Bn |
| Dec 31, 2019 | 2.21 Bn |
| Dec 31, 2019 | 2.21 Bn |
| Dec 31, 2018 | 1.95 Bn |
| Dec 31, 2018 | 1.95 Bn |
| Dec 31, 2017 | 1.96 Bn |
| Dec 31, 2017 | 1.96 Bn |
| Jun 30, 2017 | 1.04 Bn |
| Jun 30, 2017 | 1.04 Bn |
| Mar 31, 2017 | 524.00 Mn |
| Mar 31, 2017 | 524.00 Mn |
| Dec 31, 2016 | 2.11 Bn |
| Dec 31, 2016 | 2.11 Bn |
| Jun 30, 2016 | 1.04 Bn |
| Jun 30, 2016 | 1.04 Bn |
| Mar 31, 2016 | 521.00 Mn |
| Mar 31, 2016 | 521.00 Mn |
| Dec 31, 2015 | 2.11 Bn |
| Dec 31, 2015 | 2.11 Bn |
| Sep 30, 2015 | 1.57 Bn |
| Sep 30, 2015 | 1.57 Bn |
| Jun 30, 2015 | 1.04 Bn |
| Jun 30, 2015 | 1.04 Bn |
| Mar 31, 2015 | 524.00 Mn |
| Mar 31, 2015 | 524.00 Mn |
| Dec 31, 2014 | 2.09 Bn |
| Dec 31, 2014 | 2.09 Bn |
| Sep 30, 2014 | 1.57 Bn |
| Sep 30, 2014 | 1.57 Bn |
| Jun 30, 2014 | 1.02 Bn |
| Jun 30, 2014 | 1.02 Bn |
| Dec 31, 2013 | 1.29 Bn |
| Dec 31, 2013 | 1.29 Bn |
| Sep 30, 2013 | 842.00 Mn |
| Sep 30, 2013 | 842.00 Mn |
| Jun 30, 2013 | 554.00 Mn |
| Jun 30, 2013 | 554.00 Mn |
| Mar 31, 2013 | 277.00 Mn |
| Mar 31, 2013 | 277.00 Mn |
| Dec 31, 2012 | 1.09 Bn |
| Dec 31, 2012 | 1.09 Bn |
| Sep 30, 2012 | 815.00 Mn |
| Sep 30, 2012 | 815.00 Mn |
| Jun 30, 2012 | 528.00 Mn |
| Jun 30, 2012 | 528.00 Mn |
| Mar 31, 2012 | 259.00 Mn |
| Mar 31, 2012 | 259.00 Mn |
| Dec 31, 2011 | 1.06 Bn |
| Dec 31, 2011 | 1.06 Bn |
| Sep 30, 2011 | 799.00 Mn |
| Sep 30, 2011 | 799.00 Mn |
| Jun 30, 2011 | 534.00 Mn |
| Jun 30, 2011 | 534.00 Mn |
| Mar 31, 2011 | 273.00 Mn |
| Mar 31, 2011 | 273.00 Mn |
| Dec 31, 2010 | 1.02 Bn |
| Dec 31, 2010 | 1.02 Bn |
| Sep 30, 2010 | 756.00 Mn |
| Sep 30, 2010 | 756.00 Mn |
| Jun 30, 2010 | 503.00 Mn |
| Jun 30, 2010 | 503.00 Mn |
| Mar 31, 2010 | 252.00 Mn |
| Mar 31, 2010 | 252.00 Mn |
| Dec 31, 2009 | 1.05 Bn |
| Dec 31, 2009 | 1.05 Bn |
| Sep 30, 2009 | 792.00 Mn |
| Sep 30, 2009 | 792.00 Mn |
| Jun 30, 2009 | 520.00 Mn |
| Jun 30, 2009 | 520.00 Mn |